Monday, September 30, 2013

• Does Navidea's Recent Offering Make It A Buy Or Sell?at Seeking Alpha (Mon, Sep 30)

Sunday, September 29, 2013

• 2 More Bold Speculative Biotech Playsat Seeking Alpha (Sun, Sep 29)

Tuesday, September 24, 2013

• Navidea Biopharmaceuticals to Present at BioCentury’s NewsMakers in the Biotech Industry ConferenceBusiness Wire (Tue, Sep 24)
• NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial StatementsEDGAR Online (Tue, Sep 24)
• Navidea sees net proceeds of $28.8M from registered direct offering of stocktheflyonthewall.com (Tue, Sep 24)
• Navidea Biopharmaceuticals Completes $30 Million Registered Direct Offering of Common StockBusiness Wire (Tue, Sep 24)

Thursday, September 19, 2013

• Independent Investigators Report Lymphoseek® Results in JAMA Otolaryngology Head and Neck SurgeryBusiness Wire (Thu, Sep 19)
• Navidea Biopharmaceuticals Presents New Data on Precision Diagnostic Platform at Harvard ConferenceBusiness Wire (Thu, Sep 19)

Wednesday, September 18, 2013

• Here's What This $58 Billion Hedge Fund Company Is Buyingat Motley Fool (Wed, Sep 18)

Thursday, September 12, 2013

• NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial StatementsEDGAR Online (Thu, Sep 12)

Thursday, September 5, 2013

• NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, FinancEDGAR Online (Thu, Sep 5)

Wednesday, September 4, 2013

• Navidea Awarded an Additional NIH SBIR Grant for NAV4694 Beta-Amyloid Imaging Agent for Study in Mild Cognitive ImpairmentBusiness Wire (Wed, Sep 4)
• Navidea - Worth A Look?at Seeking Alpha (Wed, Sep 4)

Monday, August 26, 2013

• 3 Companies With High Short Interest And Improving Outlooksat Seeking Alpha (Mon, Aug 26)

Thursday, August 22, 2013

• 4 Healthcare Stock Stories To Cure Thursday’s Investment Illsat Wall St. Cheat Sheet (Thu, Aug 22)
• NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, FinancEDGAR Online (Thu, Aug 22)
• Tesla Eyes Production Ramp, Lockheed Martin Program Gets a Price Check, and 3 More Hot Stocksat Wall St. Cheat Sheet (Thu, Aug 22)
• Navidea Biopharmaceuticals Announces Agreement with FDA on Special Protocol Assessments for NAV5001 Phase 3 ProgramBusiness Wire (Thu, Aug 22)

Wednesday, August 21, 2013

• Navidea Awarded NIH SBIR Grant for NAV4694 Beta-Amyloid Imaging Agent Phase 3 Clinical Program Aimed at Alzheimer’s DiseaseBusiness Wire (Wed, Aug 21)
• Navidea Biopharmaceuticals Signs Manufacturing Agreement with Siemens’ PETNET Solutions for NAV4694 Beta-amyloid Imaging AgentBusiness Wire (Wed, Aug 21)

Add NAVB News to My Yahoo!